Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma.

Gozzetti, Alessandro; Defina, Marzia; Bocchia, Monica; Fabbri, Alberto; Marchini, Elena; Chitarrelli, Ida; Lauria, Francesco

Gozzetti, Alessandro; Defina, Marzia; Bocchia, Monica; Fabbri, Alberto; Marchini, Elena; Chitarrelli, Ida; Lauria, Francesco.

Leuk Res ; 34(11): e288-9, 2010 Nov.

Article in En | MEDLINE | ID: mdl-20557933

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Multiple Myeloma/drug therapy; Aged; Boronic Acids/administration & dosage; Bortezomib; Dexamethasone/administration & dosage; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Melphalan/administration & dosage; Pyrazines/administration & dosage; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Leuk Res Year: 2010 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google